{"id":"F2007B01045","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 4 of 1993)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-1993","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62517,"registerId":"commonwealth-F2007B01045-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 4 of 1993)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 4 of 1993\n\nI, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health, Housing and Community Services and Delegate of the Minister of State for Health, Housing and Community Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 April 1993.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nHexamine Mandelate\n\nPhenethicillin Potassium\n\nSodium Acid Citrate\n\nDated this tenth day of March 1993.\n\nD. GRAHAM\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health, Housing and Community Services\n\nDelegate of the Minister of State for Health, Housing and Community Services","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2214},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The declaration performs exactly the administrative function intended by section 85(2AA) of the National Health Act 1953 — removing specific pharmaceutical benefits from the scheme following committee advice. No expansion beyond the original statutory purpose."},"complexity_factors":["Very short document (less than one page)","Only 3 items listed in the operative schedule","Straightforward legal mechanism (simple delisting without conditions or exceptions)","Minimal cross-referencing (only references the enabling Act sections)"],"plain_english_summary":"This declaration removes three specific medicines — hexamine mandelate, phenethicillin potassium and sodium acid citrate — from Australia’s Pharmaceutical Benefits Scheme from 1 April 1993. Patients will pay full price, prescribers may switch to subsidised alternatives, and pharmacists lose PBS reimbursement. The change follows routine PBS value-for-money reviews to prioritise effective, cost‑efficient treatments."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-1993","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-1993/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-1993/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-1993/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-1993/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-4-of-1993/documents"}}